December 07, 2020
In re: Rotavirus Vaccines Antitrust Litigation
Case Number:
20-3460
Court:
Nature of Suit:
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 31, 2022
3rd Circ. Lets Merck Arbitrate Antitrust Suit Over Vax Prices
Antitrust claims directed at Merck Sharp & Dohme Corp. by pediatricians who allege that the company inflated vaccine prices must be arbitrated, the Third Circuit ruled Thursday, reasoning that the doctors were bound by an arbitration clause in a contract involving intermediaries between their practices and Merck.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login